Instil Bio Inc TIL

Healthcare Biotechnology

Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. The Company seeks to in-license/acquire and develop novel therapeutic candidates in diseases with significant unmet medical need. Its first such program is an engineered tumor infiltrating lymphocyte (TIL), cell therapy for the treatment of cancer. It is engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor (CoStAR), platform. The Company's lead CoStAR-TIL product candidate, ITIL-306, expresses a CoStAR molecule designed to recognize folate receptor alpha (Fra), a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC and renal cancer. CAR-T and TCR-T therapies are cell products composed of T cells that have been genetically engineered to recognize a specific cancer-related antigen on the surface of tumor cells.

NDAQ:TIL - Post by User

Instil Bio Inc

Bullboard Posts

Post by awol1on Aug 16, 2008 2:55am

1287 Views

Post# 15389373

insiders buying Aug 13-14 $176,625

Aug 14/08 Porte, Frédéric Control or Direction Acquisition in the public market Common Shares 0.180 300,000 42% 1,009,752
Aug 13/08 Porte, Frédéric Control or Direction Acquisition in the public market Common Shares 0.170 - 0.190 200,000 39% 709,752
Aug 13/08 Calais, Philippe Direct Ownership Acquisition in the public market Common Shares 0.170 - 0.190 481,000 n/a 481,000

Taken from TD insiders report.
$176,625 bought Aug 13 and 14th.

To me that shows they have some faith in the company.
Perhaps something good is in the works? Speculation on my part, no information on this...

Bullboard Posts

Gold vs. bitcoin, where should you invest?